Carmignac Gestion’s Pfizer PFE Stock Holding History

Carmignac Gestion’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$469K	Buy	+19,475	New	+$509K	0.01%	92
2023 Q2	–	Sell	-46,120	Closed	-$1.88M	–	180
2023 Q1	$1.88M	Sell	46,120 -24,336	-35%	-$1.05M	0.03%	95
2022 Q4	$3.61M	Buy	70,456 +37,312	+113%	+$1.79M	0.07%	78
2022 Q3	$1.45M	Sell	33,144 -1,166,286	-97%	-$56.7M	0.03%	84
2022 Q2	$62.9M	Sell	1,199,430 -1,447,517	-55%	-$73.8M	1.33%	24
2022 Q1	$137M	Buy	2,646,947 +711,627	+37%	+$36.9M	2.21%	18
2021 Q4	$114M	Buy	+1,935,320	New	+$95.9M	1.6%	19
2019 Q4	–	Sell	-3,399,591	Closed	-$116M	–	134
2019 Q3	$116M	Buy	+3,399,591	New	+$124M	1.46%	26

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Carmignac Gestion's PFE Position: Q2 2026 in Review

Carmignac Gestion opened a new position in Pfizer (PFE) in Q2 2026: 19,475 shares worth $469K. The stake represents 0.01% of the portfolio and ranks #92 among its holdings. This is a return to the name: Carmignac Gestion previously reported a position in PFE as recently as Q1 2023.

Carmignac Gestion first reported a position in PFE in Q3 2019 and has held it in 8 quarters since. The position peaked at $137M in Q1 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Carmignac Gestion held 19,475 shares of Pfizer worth $469K as of Q2 2026.
Pfizer was a new Carmignac Gestion position in Q2 2026.
Pfizer made up 0.01% of Carmignac Gestion's portfolio in Q2 2026, its #92 holding.
Carmignac Gestion first reported a position in Pfizer in Q3 2019 and has held it in 8 quarters since.
Carmignac Gestion's Pfizer position peaked at $137M in Q1 2022.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.